{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:24:09Z","timestamp":1787027049981,"version":"build-2736575974"},"reference-count":80,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T00:00:00Z","timestamp":1665705600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5T32HL007734 (SF, TH), 5T32DK007754 (ST), and 5T35HL11084 (AA)"],"award-info":[{"award-number":["5T32HL007734 (SF, TH), 5T32DK007754 (ST), and 5T35HL11084 (AA)"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Following Kasai hepatic portoenterostomy (HPE), most patients with biliary atresia will eventually require liver transplantation due to progressive cirrhosis and liver failure. Preventing liver transplantation, or even delaying eventual liver transplantation, is the key to improving long-term outcomes. This review first examines the commonly used adjuvant therapies in post-HPE biliary atresia and the strength of the evidence supporting these therapies. Next, it examines the evolving frontiers of management through a comprehensive evaluation of both recently completed and ongoing clinical trials in biliary atresia. Promising therapies used in other cholestatic liver diseases with potential benefit in biliary atresia are discussed. Improving post-HPE management is critical to prevent complications, delay liver transplantation, and ultimately improve the long-term survival of patients with biliary atresia.<\/jats:p>","DOI":"10.3389\/fped.2022.1007813","type":"journal-article","created":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:38:45Z","timestamp":1665722325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Current and emerging adjuvant therapies in biliary atresia"],"prefix":"10.3389","volume":"10","author":[{"given":"Scott C.","family":"Fligor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas I.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas T.","family":"Tsikis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Adeola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/S0889-8553(03)00049-9","article-title":"Biliary atresia","volume":"32","author":"Haber","year":"2003","journal-title":"Gastroenterol Clin North Am"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","article-title":"Biliary atresia: clinical and research challenges for the twenty-first century","volume":"68","author":"Bezerra","year":"2018","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/bdr2.1145","article-title":"Population-based birth defects data in the United States, 2010-2014: a focus on gastrointestinal defects","volume":"109","author":"Lupo","year":"2017","journal-title":"Birth Defects Res"},{"key":"B4","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jpeds.2017.05.006","article-title":"Incidence of biliary atresia and timing of hepatoportoenterostomy in the United States","volume":"187","author":"Hopkins","year":"2017","journal-title":"J Pediatr"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.jhep.2013.01.040","article-title":"Improving outcomes of biliary atresia: French national series 1986-2009","volume":"58","author":"Chardot","year":"2013","journal-title":"J Hepatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1007\/BF01655504","article-title":"A history of the Kasai operation: hepatic portoenterostomy for biliary atresia","volume":"12","author":"Ohi","year":"1988","journal-title":"World J Surg"},{"key":"B7","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1097\/MPG.0000000000002446","article-title":"Management of biliary atresia in France 1986 to 2015: long-term results","volume":"69","author":"Fanna","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B8","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1097\/MPG.0000000000002130","article-title":"Prognosis of biliary atresia after 2-year survival with native liver: a nationwide cohort analysis","volume":"67","author":"Witt","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MPG.0000000000000986","article-title":"Liver transplantation for biliary atresia: is there a difference in outcome for infants?","volume":"62","author":"Arnon","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B10","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2015.11.058","article-title":"Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia","volume":"170","author":"Shneider","year":"2016","journal-title":"J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/hep.21790","article-title":"Screening and outcomes in biliary atresia: summary of a National Institutes of Health workshop","volume":"46","author":"Sokol","year":"2007","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s11894-021-00825-2","article-title":"Newborn screening for biliary atresia: a review of current methods","volume":"23","author":"Rabbani","year":"2021","journal-title":"Curr Gastroenterol Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.jpeds.2015.08.041","article-title":"Complications and quality of life in long-term survivors of biliary atresia with their native livers","volume":"167","author":"Bessho","year":"2015","journal-title":"J Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1053\/j.sempedsurg.2017.09.003","article-title":"Long-term outlook in biliary atresia","volume":"26","author":"Kelay","year":"2017","journal-title":"Semin Pediatr Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1097\/MCG.0000000000000013","article-title":"Native liver histology after successful portoenterostomy in biliary atresia","volume":"48","author":"Lampela","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.surg.2017.04.013","article-title":"Molecular signature of active fibrogenesis prevails in biliary atresia after successful portoenterostomy","volume":"162","author":"Kerola","year":"2017","journal-title":"Surgery"},{"key":"B17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/gm154","article-title":"Staging of biliary atresia at diagnosis by molecular profiling of the liver","volume":"2","author":"Moyer","year":"2010","journal-title":"Genome Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1097\/MPG.0000000000002302","article-title":"Treating biliary atresia: the challenge continues","volume":"68","author":"Nijagal","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005407","article-title":"Effect of adjuvant steroid therapy in type 3 biliary atresia: a single-center, open-label, randomized controlled trial","author":"Lu","year":"2022","journal-title":"Ann Surg"},{"key":"B20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jpeds.2018.07.002","article-title":"Impact of steroid therapy on early growth in infants with biliary atresia: the multicenter steroids in biliary atresia randomized trial","volume":"202","author":"Alonso","year":"2018","journal-title":"J Pediatr"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1001\/jama.2014.2623","article-title":"Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial","volume":"311","author":"Bezerra","year":"2014","journal-title":"JAMA"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00383-013-3377-6","article-title":"Multicenter randomized trial of postoperative corticosteroid therapy for biliary atresia","volume":"29","author":"Nio","year":"2013","journal-title":"Pediatr Surg Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jhep.2013.06.012","article-title":"Steroids in biliary atresia: single surgeon, single centre, prospective study","volume":"59","author":"Davenport","year":"2013","journal-title":"J Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00383-008-2200-2","article-title":"Evaluation of a standardized protocol in the use of steroids after Kasai operation","volume":"24","author":"Chung","year":"2008","journal-title":"Pediatr Surg Int"},{"key":"B25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1572-0241.2007.01721.x","article-title":"Postoperative high-dose steroids do not improve mid-term survival with native liver in biliary atresia","volume":"103","author":"Petersen","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1002\/hep.21873","article-title":"Randomized, double-blind, placebo-controlled trial of corticosteroids after Kasai portoenterostomy for biliary atresia","volume":"46","author":"Davenport","year":"2007","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jpedsurg.2005.10.072","article-title":"Effect of corticosteroid therapy on outcomes in biliary atresia after Kasai portoenterostomy","volume":"41","author":"Escobar","year":"2006","journal-title":"J Pediatr Surg"},{"key":"B28","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0022-3468(85)80026-9","article-title":"Corticosteroid therapy in biliary atresia","volume":"20","author":"Karrer","year":"1985","journal-title":"J Pediatr Surg"},{"key":"B29","doi-asserted-by":"publisher","first-page":"CD008735","DOI":"10.1002\/14651858.CD008735.pub3","article-title":"Glucocorticosteroids for infants with biliary atresia following Kasai portoenterostomy","volume":"5","author":"Tyraskis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B30","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/jcm11030494","article-title":"Cholangitis definition and treatment after Kasai hepatoportoenterostomy for biliary atresia: a delphi process and international expert panel","volume":"11","author":"Calinescu","year":"2022","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0038-1668146","article-title":"What happens after Kasai for biliary atresia? A European multicenter survey","volume":"29","author":"Wong","year":"2019","journal-title":"Eur J Pediatr Surg"},{"key":"B32","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1053\/jpsu.2003.50128","article-title":"Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy","volume":"38","author":"Bu","year":"2003","journal-title":"J Pediatr Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s00383-021-04916-z","article-title":"Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial","volume":"37","author":"Chen","year":"2021","journal-title":"Pediatr Surg Int"},{"key":"B34","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1542\/peds.83.5.723","article-title":"Perioperative factors affecting the outcome following repair of biliary atresia","volume":"83","author":"Lally","year":"1989","journal-title":"Pediatrics"},{"key":"B35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1007\/s003830000573","article-title":"Bacterial cholangitis in patients with biliary atresia: impact on short-term outcome","volume":"17","author":"Wu","year":"2001","journal-title":"Pediatr Surg Int"},{"key":"B36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jpeds.2011.09.061","article-title":"Biliary atresia in The Netherlands: outcome of patients diagnosed between 1987 and 2008","volume":"160","author":"de Vries","year":"2012","journal-title":"J Pediatr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3389\/fmed.2020.00149","article-title":"Pediatric cholestatic liver disease: review of bile acid metabolism and discussion of current and emerging therapies","volume":"7","author":"Kriegermeier","year":"2020","journal-title":"Front Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","article-title":"Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis","volume":"71","author":"Harms","year":"2019","journal-title":"J Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"CD003626","DOI":"10.1002\/14651858.CD003626.pub2","article-title":"Bile acids for primary sclerosing cholangitis","volume":"2011","author":"Poropat","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1002\/hep.23082","article-title":"High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis","volume":"50","author":"Lindor","year":"2009","journal-title":"Hepatology"},{"key":"B41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/hep.23631","article-title":"Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression","volume":"52","author":"Sinakos","year":"2010","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/hep.1840150409","article-title":"Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease","volume":"15","author":"Beuers","year":"1992","journal-title":"Hepatology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.gastro.2005.05.009","article-title":"Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans","volume":"129","author":"Marschall","year":"2005","journal-title":"Gastroenterology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.1840160213","article-title":"Immunomodulatory effects of ursodeoxycholic acid on immune responses","volume":"16","author":"Yoshikawa","year":"1992","journal-title":"Hepatology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e14990","DOI":"10.1111\/ped.14990","article-title":"Japanese biliary atresia society. Postoperative pharmacotherapy for patients with biliary atresia in Japan","volume":"64","author":"Sakamoto","year":"2022","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e1236","DOI":"10.1542\/peds.2008-0986","article-title":"Effect of ursodeoxycholic acid on liver function in children after successful surgery for biliary atresia","volume":"122","author":"Willot","year":"2008","journal-title":"Pediatrics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.jpedsurg.2007.11.043","article-title":"Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia","volume":"43","author":"Kotb","year":"2008","journal-title":"J Pediatr Surg"},{"key":"B49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/lt.26339","article-title":"Malnutrition in biliary atresia: assessment, management, and outcomes","volume":"28","author":"Boster","year":"2022","journal-title":"Liver Transpl"},{"key":"B50","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jpeds.2005.04.073","article-title":"Biliary atresia: clinical profiles, risk factors, and outcomes of 755 patients listed for liver transplantation","volume":"147","author":"Utterson","year":"2005","journal-title":"J Pediatr"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1002\/hep.21923","article-title":"Growth failure and outcomes in infants with biliary atresia: a report from the biliary atresia research consortium","volume":"46","author":"DeRusso","year":"2007","journal-title":"Hepatology"},{"key":"B52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1080\/07315724.2020.1713654","article-title":"Genomics of detoxification: how genomics can be used for targeting potential intervention and prevention strategies including nutrition for environmentally acquired illness","volume":"39","author":"Hausman-Cohen","year":"2020","journal-title":"J Am Coll Nutr"},{"key":"B53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/jcm11040945","article-title":"Incidence, impact and treatment of ongoing CMV infection in patients with biliary atresia in four European centres","volume":"11","author":"Fischler","year":"2022","journal-title":"J Clin Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.jpedsurg.2018.12.014","article-title":"Adjuvant therapy of cytomegalovirus IgM\u202f+\u202fve associated biliary atresia: prima facie evidence of effect","volume":"54","author":"Parolini","year":"2019","journal-title":"J Pediatr Surg"},{"key":"B55","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3181\/00379727-187-42655","article-title":"Bile acid secretion and pool size during phenobarbital induced hypercholeresis","volume":"187","author":"Okuda","year":"1988","journal-title":"Proc Soc Exp Biol Med"},{"key":"B56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/S0022-3468(86)80205-6","article-title":"Effects of postoperative cholestyramine and phenobarbital administration on bile flow restoration in infants with extrahepatic biliary atresia","volume":"21","author":"Vajro","year":"1986","journal-title":"J Pediatr Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/S2468-1253(22)00093-0","article-title":"Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial","volume":"7","author":"Thompson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s40265-021-01649-0","article-title":"Maralixibat: first approval","volume":"82","author":"Shirley","year":"2022","journal-title":"Drugs"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/S0140-6736(21)01256-3","article-title":"Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study","volume":"398","author":"Gonzales","year":"2021","journal-title":"Lancet"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1038\/s41401-021-00849-4","article-title":"FXR: structures, biology, and drug development for NASH and fibrosis diseases","volume":"43","author":"Tian","year":"2022","journal-title":"Acta Pharmacol Sin"},{"key":"B61","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jsbmb.2011.06.012","article-title":"FXR And PXR: potential therapeutic targets in cholestasis","volume":"130","author":"Jonker","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1007\/s10620-006-9717-9","article-title":"The effects of N-Acetylcysteine on bile duct ligation\u2013induced liver fibrosis in rats","volume":"52","author":"Tahan","year":"2007","journal-title":"Dig Dis Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1203\/00006450-199904020-00698","article-title":"N-acetylcysteine (NAC) protects bile flow during amino acid infusion","volume":"45","author":"Shattuck","year":"1999","journal-title":"Pediatr Res"},{"key":"B65","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1067\/S0022-3476(03)00419-0","article-title":"N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial","volume":"143","author":"Ahola","year":"2003","journal-title":"J Pediatr"},{"key":"B66","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/MPG.0b013e3180653ce6","article-title":"Use of N-acetyl cysteine for the treatment of parenteral nutrition-induced liver disease in children receiving home parenteral nutrition","volume":"46","author":"Mager","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B67","doi-asserted-by":"publisher","first-page":"CD004869","DOI":"10.1002\/14651858.CD004869.pub2","article-title":"Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates","volume":"2006","author":"Soghier","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"100370","DOI":"10.1016\/j.conctc.2019.100370","article-title":"A phase 2 trial of N-acetylcysteine in biliary atresia after Kasai portoenterostomy","volume":"15","author":"Tessier","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"B69","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1007\/s11882-002-0069-z","article-title":"A history of immune globulin therapy, from the harvard crash program to monoclonal antibodies","volume":"2","author":"Berger","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"B70","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1542\/peds.9.6.722","article-title":"Agammaglobulinemia","volume":"9","author":"Bruton","year":"1952","journal-title":"Pediatrics"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1016\/S0140-6736(81)92400-4","article-title":"High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood","volume":"1","author":"Imbach","year":"1981","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.it.2008.08.004","article-title":"Modulation of the cellular immune system by intravenous immunoglobulin","volume":"29","author":"Tha-In","year":"2008","journal-title":"Trends Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1097\/MPG.0000000000002256","article-title":"A phase I\/IIa trial of intravenous immunoglobulin following portoenterostomy in biliary atresia","volume":"68","author":"Mack","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1016\/j.jhep.2021.07.033","article-title":"Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: a multicenter randomized trial (GRAFT study)","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13287-022-02762-x","article-title":"Autologous bone marrow mononuclear cell infusion for liver cirrhosis after the Kasai operation in children with biliary atresia","volume":"13","author":"Nguyen","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B76","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1053\/j.gastro.2020.10.001","article-title":"Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double-blind, randomized, placebo-controlled trial","volume":"160","author":"de Vries","year":"2021","journal-title":"Gastroenterology"},{"key":"B77","doi-asserted-by":"publisher","first-page":"698900","DOI":"10.3389\/fimmu.2021.698900","article-title":"Association of gut microbiota and metabolites with disease progression in children with biliary atresia","volume":"12","author":"Song","year":"2021","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"101753","DOI":"10.1016\/j.clinre.2021.101753","article-title":"Assessment of lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - randomized placebo controlled trial","volume":"45","author":"Or\u0142owska","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/MPG.0000000000000676","article-title":"Use of lactobacillus casei rhamnosus to prevent cholangitis in biliary atresia after kasai operation","volume":"60","author":"Lien","year":"2015","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1053\/j.sempedsurg.2012.05.002","article-title":"Biliary atresia: the animal models","volume":"21","author":"Petersen","year":"2012","journal-title":"Semin Pediatr Surg"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1007813\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,14]],"date-time":"2022-10-14T04:38:50Z","timestamp":1665722330000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1007813\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,14]]},"references-count":80,"alternative-id":["10.3389\/fped.2022.1007813"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1007813","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,14]]},"article-number":"1007813"}}